Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Using RNAi in the clinic.

Dev, Kumlesh K (2006) Using RNAi in the clinic. IDrugs : the investigational drugs journal, 9 (4). pp. 279-282. ISSN 1369-7056


RNA interference (RNAi) is a biological process that controls gene silencing in all living cells. Targeting the RNAi system represents a novel therapeutic strategy that has the ability to intercede with multiple disease-related genes and so target many human diseases. Recently, the design of small interfering RNA (siRNA)-selective compounds has become more straightforward because of the significant progress made in predictive modeling. Exciting new data show that siRNA blocks gene function in vivo, suggesting that it has potential as a therapeutic approach for humans. This article highlights recent advances in siRNA research and discusses the aims of the pharmaceutical and biotechnology industries to progress siRNA compounds into the clinical. In the fight against disease, the use of RNAi is a powerful new tactic that adds to the arsenal of small-molecule inhibitors and antibody-blocking approaches.

Item Type: Article
Related URLs:
Additional Information: author can archive post-print (ie final draft post-refereeing); On a non-profit server
Keywords: Clinical trials; in vivo; siRNA drugs
Related URLs:
Date Deposited: 14 Dec 2009 14:00
Last Modified: 14 Dec 2009 14:00


Email Alerts

Register with OAK to receive email alerts for saved searches.